Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis

Completed · Phase 2/Phase 3

Conditions studied: Distal and Lateral Subungual Onychomycosis

In brief

The purpose of this study is to determine the safety and efficacy of a topical antifungal formulation, Luliconazole Solution, 10%, in the treatment of adults with onychomycosis of the toenails.

Key facts

Study ID

NCT01431820

Run by

Topica Pharmaceuticals

People needed

334

Starts

2012-05-01

Expected to finish

2014-08-01

Last updated by the study team

2015-11-30

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects of either gender, any race and between the ages of 18 and 70 inclusive
• Subjects with a clinical diagnosis with culture confirmation of distal subungual onychomycosis (DSO) - Subjects must be free of any disease that in the Investigator's opinion might interfere with the study evaluations or jeopardize the subject's safety

You may not qualify if…

• Subjects with a history of intolerance or hypersensitivity to imidazole compounds or the inactive components of the solution
• Subjects who are currently participating or have recently participated in another investigational medication or device study

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Los Angeles, California, United States
• Study site — San Diego, California, United States
• Study site — San Diego, California, United States
• Study site — Denver, Colorado, United States
• Study site — Aventura, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Boise, Idaho, United States
• Study site — Evansville, Indiana, United States
• Study site — Louisville, Kentucky, United States
• Study site — Baltimore, Maryland, United States
• Study site — Detroit, Michigan, United States
• Study site — Fridley, Minnesota, United States
• Study site — Albuquerque, New Mexico, United States
• Study site — East Setauket, New York, United States
• Study site — Rochester, New York, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Portland, Oregon, United States
• Study site — Portland, Oregon, United States
• Study site — Knoxville, Tennessee, United States
• Study site — Nashville, Tennessee, United States
• Study site — Austin, Texas, United States
• Study site — College Station, Texas, United States
• Study site — Dallas, Texas, United States
• Study site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.